Tae‐Hoon Chung

Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma

W-J Chng, G F Huang, Tae‐Hoon Chung et al. · Leukemia · 2011 · 276 citations

Hematological Malignancy, Tumor Biology, Biological Implications +10

Molecular Dissection of Hyperdiploid Multiple Myeloma by Gene Expression Profiling

Wee Joo Chng, Shaji Kumar, Scott VanWier et al. · Cancer Research · 2007 · 257 citations

EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma

Junli Yan, Boheng Li, Baohong Lin et al. · Blood · 2016 · 134 citations · Full text

Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes

Siok‐Bian Ng, Tae‐Hoon Chung, Seiichi Kato et al. · Haematologica · 2017 · 118 citations · Full text

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

Phaik Ju Teoh, Ömer An, Tae‐Hoon Chung et al. · Blood · 2018 · 103 citations · Full text